|
Product complaint # (b)(4).This report is being submitted pursuant to the provisions of 21 cfr, part 803 (and/or part 4, as applicable).This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by depuy synthes, or its employees that the report constitutes an admission that the product, depuy synthes, or its employees caused or contributed to the potential event described in this report.Additional narrative: h3, h6: investigation summary no device associated with this report was received for examination.A search of the medtech orthopedics nonconformance (nc) quality system found no nc¿s associated with this product 136528740/lot 4561486 combination.As part of our company quality system process, all devices are manufactured, inspected, and distributed to approved specifications.Additional complaint information monitoring for potential safety signals will be conducted through complaint trending as part of the post-market surveillance.If additional information is made available, the investigation will be updated as applicable.If information is obtained that was not available for the initial medwatch, a follow-up medwatch will be filed as appropriate.
|
|
It was reported that the patient present post revision tha with a dislocated hip.After appropriate exposure has taken place, the hip is relocated and found to be extremely stable, being able to be both internally and externally rotated to extreme positions without dislocating.Frozen section did show 5 white cells per high powered field which was somewhat concerning.A thorough i&d is performed due to this finding and elevated labs and resorbable antibiotic beads are placed.New components are placed with no patient harm or delay.Affected side: left hip.
|